Literature DB >> 10799441

Monitoring of antigen-specific cytolytic T lymphocytes in cancer patients receiving immunotherapy.

T L Whiteside1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10799441      PMCID： PMC95874          DOI： 10.1128/CDLI.7.3.327-332.2000

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


× No keyword cloud information.
  58 in total

1.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules.

Authors:  K Falk; O Rötzschke; S Stevanović; G Jung; H G Rammensee
Journal:  Nature       Date:  1991-05-23       Impact factor: 49.962

Review 2.  Consensus motifs and peptide ligands of MHC class I molecules.

Authors:  K Falk; O Rötzschke
Journal:  Semin Immunol       Date:  1993-04       Impact factor: 11.130

Review 3.  Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay.

Authors:  T L Whiteside; J Bryant; R Day; R B Herberman
Journal:  J Clin Lab Anal       Date:  1990       Impact factor: 2.352

4.  Detection of intracellular cytokines by flow cytometry.

Authors:  T Jung; U Schauer; C Heusser; C Neumann; C Rieger
Journal:  J Immunol Methods       Date:  1993-02-26       Impact factor: 2.303

5.  Preferential clonogenic deficit of CD8-positive T-lymphocytes infiltrating human solid tumors.

Authors:  S Miescher; M Stoeck; L Qiao; C Barras; L Barrelet; V von Fliedner
Journal:  Cancer Res       Date:  1988-12-15       Impact factor: 12.701

6.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  P van der Bruggen; C Traversari; P Chomez; C Lurquin; E De Plaen; B Van den Eynde; A Knuth; T Boon
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

Review 7.  The role of CD4+ T cell responses in antitumor immunity.

Authors:  D M Pardoll; S L Topalian
Journal:  Curr Opin Immunol       Date:  1998-10       Impact factor: 7.486

8.  Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells.

Authors:  P G Coulie; M Somville; F Lehmann; P Hainaut; F Brasseur; R Devos; T Boon
Journal:  Int J Cancer       Date:  1992-01-21       Impact factor: 7.396

9.  Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire.

Authors:  S A Kalams; R P Johnson; A K Trocha; M J Dynan; H S Ngo; R T D'Aquila; J T Kurnick; B D Walker
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

10.  A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.

Authors:  C Traversari; P van der Bruggen; I F Luescher; C Lurquin; P Chomez; A Van Pel; E De Plaen; A Amar-Costesec; T Boon
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307
View more
  4 in total

Review 1.  Development and use of multimeric major histocompatibility complex molecules.

Authors:  Tim F Greten; Jonathan P Schneck
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assay.

Authors:  A Samri; C Durier; A Urrutia; I Sanchez; H Gahery-Segard; S Imbart; M Sinet; E Tartour; J-P Aboulker; B Autran; A Venet
Journal:  Clin Vaccine Immunol       Date:  2006-06

Review 3.  Overview of a HLA-Ig based "Lego-like system" for T cell monitoring, modulation and expansion.

Authors:  Mathias Oelke; Jonathan P Schneck
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

4.  Escherichia coli adhesin protein-conjugated thermal responsive hybrid nanoparticles for photothermal and immunotherapy against cancer and its metastasis.

Authors:  Juyoung Hwang; Wei Zhang; Hae-Bin Park; Dhananjay Yadav; Yong Hyun Jeon; Jun-O Jin
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.